E-nitiate Biopharmaceuticals has raised $14M in total funding. Latest round: Series A. Backed by Time Investment, Taikun Fund, Linping State Investment.
E-nitiate Biopharmaceuticals has raised $14M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in April 2023. The round record for E-nitiate Biopharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund. 4 distinct backers are named across the disclosed rounds.
Every E-nitiate Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide